Plenary Lecture
-
Plenary Lecture 1
Breaking new ground: Innovative cancer vaccine therapies
Patrick Ott
Dana-Farber Cancer Institute
USA
CV
-
Plenary Lecture 2
Cancer cachexia: Transition from science to practice
Jeffrey Crawford
Duke Cancer Center
USA
CV
-
Plenary Lecture 3
Advances in chemotherapy for gastric cancer- Future perspectives
Kohei Shitara
National Cancer Center Hospital East
Japan
CV
-
Plenary Lecture 4
Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer
Giuseppe Curigliano
European Institute of Oncology, IRCCS and Università degli Studi di Milano
Italy
CV
JOINT SYMPOSIUM
Joint Symposium 1 (ASCO/KSMO)
-
Samuel Klempner
Massachusetts General Hospital
USA
CV
-
Jeeyun Lee
Samsung Medical Center
Korea
CV
-
-
Joint Symposium 2 (KCSG/KSMO)
Transforming oncology research: AI-powered clinical trials
-
Hiromizu Takahashi
Juntendo University Urayasu Hospital
Japan
CV
-
Kenneth Kehl
Dana-Farber Cancer Institute
USA
CV
-
-
Joint Symposium 3 (KOSRO /KSMO)
Optimization of neoadjuvant/adjuvant treatment
-
-
-
Jang Ho Cho
Gachon University Gil Medical Center
Korea
CV
-
Jeong Il Yu
Samsung Medical Center
Korea
CV
Joint Symposium 4 (ESMO/KSMO)
ESMO guideline and the implementation in Asian Pacific region
Joint Symposium 5 (KSSO/KSMO)
Omit surgery in GI cancer treatment
-
-
Minsu Kang
Seoul National University Bundang Hospital
Korea
CV
-
-
Joint Symposium 6 (KSR/KSMO)
Joint Symposium 7 (JSMO/KSMO)
The new standard therapy in solid tumors : The combination of immunotherapies
-
Junho Lee
Kyung Hee University Hospital
Korea
CV
-
Hong sik Kim
Chungbuk National University Hospital
Korea
CV
-
Kenjiro Namikawa
National Cancer Center Hospital, Tokyo
Japan
CV
-
Kenji Tamura
Shimane University Hospital
Japan
CV
Joint Symposium 8 (KSP/KSMO)
Biomarker for ADC
Joint Symposium 9 (ASCO/KSMO)
-
-
-
-
Hyo song Kim
Yonsei University College of Medicine
Korea
CV
Joint Symposium 10 (ESMO/KSMO)
How to streamline initiatives for optimising oncology practice
SCIENTIFIC SYMPOSIUM
Scientific Symposium 1
Optimizing the transition to palliative care: Prognostic estimation and communication in oncology
Scientific Symposium 2
Revolutionizing GI cancer care with next-generation modalities
Scientific Symposium 3
How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead
Scientific Symposium 4
Current trends and future perspectives in GU oncology
-
-
-
Hyeon-Su Im
Ulsan University Hospital
Korea
CV
-
Hyunho Kim
The Catholic University of Korea St. Vincent's Hospital
Korea
CV
Scientific Symposium 5
Current Insights and future directions of MBC treatment
-
-
-
Kyong Hwa Park
Korea University Anam Hospital
Korea
CV
-
Gun Min Kim
Yonsei University College of Medicine
Korea
CV
Scientific Symposium 6
Clinical promise of ctDNA-based MRD testing in cancer therapy
-
-
-
Takayuki Yoshino
National Cancer Center Hospital East
Japan
CV
-
Scientific Symposium 7
Novel opportunities to target cancer: Emerging strategies in molecular oncology
-
-
Erica Sloan
Monash University
Australia
CV
-
-
Scientific Symposium 8
Combinatory strategy to enhance immune checkpoint response
-
Changhoon Yoo
Asan Medical Center, University of Ulsan College of Medicine
Korea
CV
-
-
-
Kyung Hwan Kim
Yonsei Cancer Center
Korea
CV
Scientific Symposium 9
Real-world challenges in GI oncology: Navigating complex treatment decisions
-
-
Choong-kun Lee
Yonsei Cancer Center
Korea
CV
-
Choong-kun Lee
Yonsei Cancer Center
Korea
CV
-
Raghav Sundar
Yale School of Medicine
USA
CV
Scientific Symposium 10
Revealing immune response and resistance through spatial profiling of NSCLC microenvironment
MULTI-DISCIPLINARY CASE DISCUSSION
Multi-Disciplinary Case Discussion (KOREAN)
Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics
-
Chai Hong Rim
Korea University College of Medicine
Korea
CV
-
In Hee Lee
Kyungpook National University Chilgok Hospital
Korea
CV
-
Dae-Won Lee
Seoul National University College of Medicine
Korea
CV
-
Hwa Kyung Byun
Yongin Severance Hospital
Korea
CV
EDUCATION SESSION
Education Session 1
Symptom management in advanced cancer: Innovations and best practices
-
-
-
-
Hee Kyung Ahn
Samsung Medical Center
Korea
CV
Education Session 2 (KOREAN)
Tumor heterogeneity and single-cell analysis
-
Jinhyuk Bhin
Yonsei University College of Medicine
Korea
CV
-
-
Hoon Hur
Ajou University School of Medicine
Korea
CV
-
Yunhak Kim
Pusan National University
Korea
CV
Education Session 3 (KOREAN)
Cancer survivorship: Shifting paradigms in care
-
-
Ji Soo Park
Cancer Prevention Center, Yonsei Cancer Center
Korea
CV
-
Seockhoon Chung
Asan Medical Center
Korea
CV
-
Education Session 4 (KOREAN)
Toxicity management in Antibody-Drug Conjugates (ADCs)
-
In Hae Park
Korea University Guro Hospital
Korea
CV
-
Han Jo Kim
Soonchunhyang University Cheonan Hospital
Korea
CV
-
Jimyung Park
Seoul National University Hospital
Korea
CV
-
Chang Ho Yoon
Seoul National University Hospital
Korea
CV
Education Session 5 (KOREAN)
Advance of technology - Artificial intelligence in oncology
-
Chanyoung Ock
Bang & Ock Consulting Inc.
Korea
CV
-
Eunkyung Kim
Yonsei University College of Medicine
Korea
CV
-
Yoon Jin Cha
Gangnam Severance Hospital
Korea
CV
-
FACO SESSION
FACO Session 1
Recent updates in colorectal cancer treatment
-
Ying Yuan
The Second Affiliated Hospital Zhejiang University School of Medicine
China
CV
-
Eiji Oki
Kyushu University
Japan
CV
FACO Session 2
Proposals for new FACO clinical trials
-
Sehhoon Park
Samsung Medical Center
Republic of Korea
CV
-
Ning Li
Cancer Hospital Chinese Academy of Medical Sciences
China
CV
-
Keiichi Fujiwara
Saitama Medical University International Medical Center
Japan
CV